Le Lézard
Classified in: Health
Subjects: CHI, POL, AVO, DEI

Blythedale Children's Hospital CEO: Build Back Better for Kids


VALHALLA, N.Y., Oct. 30, 2021 /PRNewswire/ -- The following is a statement from the CEO of Blythedale Children's Hospital:

Congress is debating the proposed $3.5 trillion social infrastructure legislation against a backdrop of searing political divisions. The focus has been on total cost and choosing which initiatives to cut out or cut back. But there is one area that can unite us all?red and blue states, conservatives, moderates, and progressives: children's health and well-being. Money spent on kids is not just an expenditure, it's an investment in strengthening our country that will pay future dividends for us all.  

As a children's hospital CEO, I watch kids of all racial and economic backgrounds, and families of all political affiliations, come through our doors. In the blink of an eye, their lives have been turned upside down, often by a devastating diagnosis. All our nation's schisms vanish as they enter; politics becomes suddenly, and completely, irrelevant. Each child is simply a patient needing care, and our mission is to provide the very best care possible.  

Due to vast research on social determinants of health, we also know that it is essential to kids' physical health and cognitive development to meet a child's basic needs: food, clothing, housing, consistent and prompt medical care, and early childhood education. An ounce of prevention is resoundingly worth a pound of cure.

After 45 years in the children's hospital field, I consider it my responsibility to advocate for what I've learned is vital to the health and quality of life of children. I call upon Congress to adopt the following pro-working families agenda within Build Back Better:

I can already hear the criticism that "We don't have the money to pay for this"?except that we do. What has been lacking is the political will to readjust priorities. Let's recognize that our budget is not just a financial document; it's also our most fundamental statement of values as a society. And how to pay for improvements in children's health and well-being? To begin with, redirect the billions annually spent in Afghanistan; recoup hundreds of billions of dollars in savings by allowing the federal government to negotiate the cost of pharmaceuticals; and re-examine the fairness of our tax policies.

Congress, as you negotiate Build Back Better, put children and families at the top of your agenda.? Protecting them ensures a better present and future for our nation. And, because it benefits both red and blue state families, it's even good politics as well.

Larry Levine is the President & CEO of Blythedale Children's Hospital in New York, a position he has held for the last 20 years. Mr. Levine's opinions are based upon his 45 years of work in the children's hospital field, talking to parents about their families and children's needs. 

SOURCE Blythedale Children's Hospital


These press releases may also interest you

at 14:06
On Wednesday, May 15, Red Door Community hosted their annual Celebrating Women Working and Living with Cancer Luncheon at the Metropolitan Club in New York City. The event raised more than $300,000 while shining a light on the women who inspire us...

at 14:05
Product: Kalihim (Philippine Bread Roll) Issue: Food - Allergen - Egg Distribution: British Columbia See the affected products and product photos for this recall SOURCE Canadian Food Inspection Agency (CFIA)

at 13:27
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...

at 11:03
Boston Scientific Corporation today announced positive six-month results from the ongoing pivotal MODULAR ATP clinical trial of the mCRMtm System,* the first modular cardiac rhythm management (CRM) system that consists of the EMBLEMtm Subcutaneous...

at 08:35
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...

at 07:05
Mirum Pharmaceuticals, Inc. today announced data presented during the 56th European Society for Paediatric, Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Annual Meeting which took place this week in Milan, Italy. Data from LIVMARLI®...



News published on and distributed by: